Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

COVID-19 is characterized by a dysregulation of inflammatory cytokines ultimately resulting a cytokine storm that can result in significant morbidity and mortality. We developed an in-vitro assay using activated peripheral blood mononuclear cells (PBMCs) stimulated with lipopolysaccharide (LPS) or C...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathi, Kavita, Rosenberg-Hasson, Yael, Maecker, Holden, Carlo, Dennis J., Moss, Ronald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378988/
https://www.ncbi.nlm.nih.gov/pubmed/34425240
http://dx.doi.org/10.1016/j.clim.2021.108828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378988/
https://www.ncbi.nlm.nih.gov/pubmed/34425240
http://dx.doi.org/10.1016/j.clim.2021.108828

Ejemplares similares